fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

MindMatters White Logo

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Subscribe to MindMatters

Taking Control of Your Brain Metastases Care

Priya KumtheKar, MD

Did you know that when a tumor spreads to the brain, it is not called brain cancer?

Rather, it is named after the part of the body where the cancer started. Lung cancer that spreads to the brain is called metastatic lung cancer, breast cancer that spreads to the brain is called metastatic breast cancer, and so on. 

Metastatic brain tumors are the most common brain tumor type among adults. Approximately 200,000 adults are diagnosed each year in the US. Lung, breast, kidney, colon, and melanoma (skin) cancers are typically the most common cancers that spread to the brain. 

To better serve this often-overlooked patient population, the ABTA created the Metastatic Brain Tumor Collaborative, a partnership between cancer organizations that aims to collectively advance research and provide more patient and caregiver resources. The ABTA has free educational brochuressupport services and tools to help those affected by a metastatic brain tumor.  

Patients, survivors, and loved ones are invited to join us Saturday, June 17 for Navigating Your Brain Metastases Care, a free, half-day virtual meeting designed to help patients with or at risk of metastatic brain tumors and their caregivers navigate treatment.  

Meeting topics include: 

Meeting Chair Priya Kumthekar, MD

This meeting is chaired by Priya Kumthekar, MD, Director of the Brain Metastases Program at the Northwestern University Feinberg School of Medicine. You don’t want to miss it!

Click below to see the full program and register.

Note: This event will have Spanish closed captioning available (Este evento tendrá subtítulos en español disponibles!)

Picture of Jessie Schlacks

Jessie Schlacks

Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.


 

Make a Difference Today

Your generosity fuels progress. The American Brain Tumor Association has already invested over $35 million in life-changing brain tumor research, leading to breakthroughs like the FDA approval of vorasidenib, a groundbreaking treatment for low-grade glioma. Let’s come together to create more breakthroughs.

🤍 Join us in bringing hope and advancing care. Donate now.

Share This Content:

Share:

More Posts

Upcoming Events

Educational Resources

Always free for patients & caregivers

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Your Gift Matched!

Make an end-of-year gift now and your gift will be matched thanks to the family of Connie Fischer.